# Purui Life Sciences raises CNY 100 million in Series A funding

On 2026/6/30, Xiniu Data reported that Purui Life Sciences completed CNY 100 million in Series A funding, led by Dongrong Fund One (Zhuhai Hengqin) Equity Investment Partnership (Limited Partnership), with participation from Sumitomo Corporation Asia Capital, Suzhou Rongsheng Xianxing Venture Investment Partnership (Limited Partnership), Suzhou High-Tech Science and Technology Innovation Angel Phase One Venture Investment Partnership (Limited Partnership), Qiming Venture Partners, IQVIA, and others. The company provides digital and intelligent clinical research services.



Canonical: https://uniquebase.ai/news/8fe9a4cb-ff94-4a17-8e65-7a503311b151
Stable identifier: 8fe9a4cb-ff94-4a17-8e65-7a503311b151
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:21:37.625Z

## Connected profiles

- [Dongrongyihao (Zhuhai Hengqin) Guquan Investment Partnership (Limited Partnership)](/institutions/dongrongyihao-zhuhai-hengqin-guquan-investment-partnership-limited-partnership)
- [IQVIA](/institutions/iqvia)
- [Purui Technology](/companies/UB-C5836)
- [Qiming Venture Capital](/institutions/qiming-venture-capital)
- [Suzhou Gaoxinkechuangtianshi Phase One Venture Capital Partnership (Limited Partnership)](/institutions/suzhou-gaoxinkechuangtianshi-phase-one-venture-capital-partnership-limited-partnership)
- [Suzhou Rongshengxianxing Venture Capital Partnership (Limited Partnership)](/institutions/suzhou-rongshengxianxing-venture-capital-partnership-limited-partnership)
- [Zhuyoushangshiyazhou Capital](/institutions/zhuyoushangshiyazhou-capital)

## Sources

- No source links are available for this profile.